FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kalipso Chalkidou

Research Profile

Geographic Areas

Concepts & Ideas

Occupations

Evidence-Based Medicine

Physiology

Decision Making

Procedures

Activities & Behaviors

Disorders

Neoplasms

Co-author Network

Publications

TOP 3
Corinna Sorenson; Michael Drummond; Kalipso Chalkidou
Comparative effectiveness research: the experience of the National Institute for Health and Clinical Excellence.
Kalipso Chalkidou
Evidence and values: paying for end-of-life drugs in the British NHS.
Kalipso Chalkidou; Robert Fowler; Sean R. Tunis; Danielle Whicher; Merrick Zwarenstein
The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kalipso Chalkidou (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Corinna Sorenson; Michael Drummond; Kalipso Chalkidou
Comparative effectiveness research: the experience of the National Institute for Health and Clinical Excellence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(34):4267-74.
2012: Kalipso Chalkidou
Evidence and values: paying for end-of-life drugs in the British NHS.
Health economics, policy, and law 2012;7(4):393-409.
2012: Kalipso Chalkidou; Robert Fowler; Sean R. Tunis; Danielle Whicher; Merrick Zwarenstein
The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.
Clinical trials (London, England) 2012;9(4):436-46.
2012: Peter Littlejohns; Kalipso Chalkidou; Ruth R Faden; Albert Weale; Yot Teerawattananon
Social values and health policy: a new international research programme.
Journal of health organization and management 2012;26(3):285-92.
2011: Kalipso Chalkidou; Michael Rawlins
Pharmacogenetics and cost-effectiveness analysis: a two-way street.
Drug discovery today 2011;16(19-20):873-7.
2011: Michael D Rawlins; Kalipso Chalkidou
The opportunity cost of cancer care: a statement from NICE.
The lancet oncology 2011;12(10):931-2.
2011: A Stevens; Kalipso Chalkidou; P Littlejohns
The NHS: assessing new technologies, NICE and value for money.
Clinical medicine (London, England) 2011;11(3):247-50.
2011: Ruth R Faden; Kalipso Chalkidou
Determining the value of drugs--the evolving British experience.
The New England journal of medicine 2011;364(14):1289-91.
2011: Kalipso Chalkidou; Joanne Lord; Nour A Obeidat; Ibriham A Alabbadi; Adrian G Stanley; Rania Bader; Aiman Momani; Rachel M O'Mahony; Lara Qatami; Derek Cutler
Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care.
International journal of technology assessment in health care 2011;27(2):151-8.
2011: Kalipso Chalkidou; Gerard F Anderson; Ruth R Faden
Eliminating drug price differentials across government programmes in the USA.
Health economics, policy, and law 2011;6(1):43-64.
2010: Kalipso Chalkidou; Tom Walley
Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and future.
PharmacoEconomics 2010;28(10):799-811.
2010: Kalipso Chalkidou; Ruth Levine; Andrew Dillon
Helping poorer countries make locally informed health decisions.
BMJ (Clinical research ed.) 2010;341():c3651.
2010: Andrew Briggs; Karen Ritchie; Elisabeth Fenwick; Kalipso Chalkidou; Peter Littlejohns
Access with evidence development in the UK: past experience, current initiatives and future potential.
PharmacoEconomics 2010;28(2):163-70.
2009: Ruth R Faden; Kalipso Chalkidou; John Appleby; Hugh R Waters; Jonathon P Leider
Expensive cancer drugs: a comparison between the United States and the United Kingdom.
The Milbank quarterly 2009;87(4):789-819.
2009: Danielle M Whicher; Kalipso Chalkidou; Irfan A Dhalla; Leslie Levin; Sean R. Tunis
Comparative effectiveness research in Ontario, Canada: producing relevant and timely information for health care decision makers.
The Milbank quarterly 2009;87(3):585-606.
2009: John Appleby; Nancy Devlin; David Parkin; Martin Buxton; Kalipso Chalkidou
Searching for cost effectiveness thresholds in the NHS.
Health policy (Amsterdam, Netherlands) 2009;91(3):239-45.
2009: Kalipso Chalkidou
Comparative effectiveness review within the U.K.'s National Institute for Health and Clinical Excellence.
Issue brief (Commonwealth Fund) 2009;59():1-12.
2009: Irfan A Dhalla; Sarah Garner; Kalipso Chalkidou; Peter Littlejohns
Perspectives on the National Institute for Health and Clinical Excellence's recommendations to use health technologies only in research.
International journal of technology assessment in health care 2009;25(3):272-80.
2009: Kalipso Chalkidou; Danielle Whicher; Weslie Kary; Sean R. Tunis
Comparative effectiveness research priorities: identifying critical gaps in evidence for clinical and health policy decision making.
International journal of technology assessment in health care 2009;25(3):241-8.
2009: Kalipso Chalkidou; Sean R. Tunis; Ruth Lopert; Lise Rochaix; Peter T Sawicki; Mona Nasser; bertrand XERRI
Comparative effectiveness research and evidence-based health policy: experience from four countries.
The Milbank quarterly 2009;87(2):339-67.
2009: Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas Altman; Sean R. Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2009;180(10):E47-57.
2009: Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas Altman; Sean R. Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
Journal of clinical epidemiology 2009;62(5):464-75.
2009: David Barnett; Kalipso Chalkidou; Michael Rawlins
Comparative effectiveness research: a useful tool.
Health affairs (Project Hope) 2009;28(2):600-1; author reply 601.
2008: Kalipso Chalkidou; Joanne Lord; Alastair Fischer; Peter Littlejohns
Evidence-based decision making: when should we wait for more information?
Health affairs (Project Hope) 2008;27(6):1642-53.
2008: Kalipso Chalkidou; Tom Walley; Anthony Culyer; Peter Littlejohns; Andrew Hoy
Evidence-informed evidence-making.
Journal of health services research & policy 2008;13(3):167-73.
2008: Gerard F Anderson; Kalipso Chalkidou
Spending on medical care: more is better?
JAMA : the journal of the American Medical Association 2008;299(20):2444-5.
2008: Kalipso Chalkidou; Anthony Culyer; Bhash Naidoo; Peter Littlejohns
Cost-effective public health guidance: asking questions from the decision-maker's viewpoint.
Health economics 2008;17(3):441-8.
2007: Kalipso Chalkidou; Andrew Hoy; Peter Littlejohns
Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research.
Journal of the Royal Society of Medicine 2007;100(10):453-60.
2007: Sean R. Tunis; Kalipso Chalkidou
Coverage with evidence development: a very good beginning, but much to be done. Commentary to Hutton et al.
International journal of technology assessment in health care 2007;23(4):432-5.
2006: Polly Brown; Klara Brunnhuber; Kalipso Chalkidou; Iain Chalmers; Mike Clarke; Mark Fenton; Carol Forbes; Julie Glanville; Nicholas J Hicks; Janet Moody; Sara Twaddle; Hazim Timimi; Pamela Young
How to formulate research recommendations.
BMJ (Clinical research ed.) 2006;333(7572):804-6.